Try our mobile app
US Leaders — Screener 
Technology
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Google 383.22 +0.3% 0.2% -0.1% 
15.9% 
13.3%
14.6% 
13.7%
 34.3x
Apple 280.14 +3.2% 0.4% 1.1% 
15.7% 
17.8%
16.7% 
5.2%
 29.3x
Microsoft 414.44 +1.6% 0.8% 1.1% 
16.7% 
23.4%
20.0% 
19.3%
 16.6x
Amazon 268.26 +1.2% 0.0% 0.0% 
13.6% 
20.7%
17.2% 
26.1%
 18.8x
Broadcom 421.28 +0.9% 0.6% 1.4% 
29.5% 
36.1%
32.8% 
26.2%
 70.9x
Facebook 608.75 -0.5% 0.3% 0.0% 
23.8% 
8.4%
16.1% 
32.9%
 16.2x
Netflix 92.06 -1.7% 0.0% 2.2% 
17.2% 
11.6%
14.4% 
23.8%
 30.6x
Texas Instruments 281.02 0.0% 2.0% -0.7% 
10.4% 
12.0%
11.2% 
-6.0%
 33.1x
Salesforce 183.82 +4.1% 0.9% 0.8% 
8.6% 
11.0%
9.8% 
24.5%
 13.2x
Adobe 250.71 +1.9% 0.0% 1.2% 
10.5% 
12.4%
11.5% 
12.7%
 12.0x
Payments
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Visa 328.03 -0.5% 0.8% --- 
11.5% 
-4.3%
3.6% 
6.5%
 30.8x
Mastercard 495.46 -1.5% 0.6% --- 
17.6% 
21.5%
19.5% 
9.6%
 32.1x
Hardware
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Nvidia 198.45 -0.6% 0.0% 0.6% 
73.2% 
83.5%
78.4% 
109.8%
 36.3x
QUALCOMM 177.01 -1.4% 2.0% 0.0% 
5.0% 
-5.8%
-0.4% 
2.2%
 14.7x
Communications
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Cisco 91.85 +0.4% 1.8% 1.3% 
7.5% 
26.1%
16.8% 
2.8%
 24.9x
Verizon 48.11 +0.2% 5.7% 3.3% 
1.5% 
22.5%
12.0% 
4.2%
 7.3x
AT&T 26.12 0.0% 4.2% -0.7% 
3.6% 
2.0%
2.8% 
13.4%
 7.6x
Comcast 27.19 +0.6% 4.7% 4.3% 
-2.7% 
-1.9%
-2.3% 
9.4%
 5.6x
Entertainment
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Disney 103.08 -0.6% 1.5% 0.1% 
5.2% 
-3.0%
1.1% 
26.1%
 12.3x
Consumer Brand
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Procter & Gamble 147.26 +0.1% 2.9% -0.4% 
1.5% 
-4.3%
-1.4% 
5.3%
 16.9x
Coca-Cola 78.58 -0.2% 2.6% -0.1% 
2.4% 
-30.4%
-14.0% 
7.0%
 25.1x
Philip Morris 166.38 +0.8% 3.4% -0.4% 
9.4% 
14.8%
12.1% 
8.6%
 18.4x
PepsiCo 157.41 -0.7% 3.6% -1.6% 
5.6% 
42.6%
24.1% 
6.0%
 16.6x
Nike 44.40 +0.1% 3.6% -2.0% 
0.6% 
-27.8%
-13.6% 
-13.3%
 85.2x
Food
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
McDonalds 286.64 -2.4% 2.5% -0.5% 
3.0% 
0.2%
1.6% 
6.7%
 19.0x
Retail
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Walmart 131.60 -0.3% 0.7% -0.5% 
5.6% 
10.8%
8.2% 
9.5%
 25.6x
Costco Wholesale 1 011.70 -0.3% 0.5% 1.1% 
15.0% 
12.8%
13.9% 
9.3%
 34.6x
Home Depot 323.88 -1.5% 2.8% 1.1% 
-3.8% 
-11.6%
-7.7% 
-0.9%
 16.4x
Pharma
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Eli Lilly 963.33 +3.1% 0.6% -0.6% 
53.9% 
200.0%
126.9% 
44.0%
 36.0x
Johnson & Johnson 227.19 -1.2% 2.3% -1.6% 
6.8% 
78.8%
42.8% 
16.4%
 16.1x
AbbVie 206.60 -2.2% 3.2% -0.2% 
10.0% 
0.0%
5.0% 
-1.5%
 27.0x
United Health 368.78 -0.5% 2.4% -2.5% 
12.2% 
-44.5%
-16.1% 
6.6%
 13.3x
Merck 112.16 +2.7% 3.0% 0.1% 
3.7% 
49.7%
26.7% 
9.1%
 11.6x
Thermo Fisher Scientific 469.21 -2.0% 0.4% -22.8% 
4.9% 
5.5%
5.2% 
-3.2%
 21.9x
Abbott 89.46 -1.5% 2.7% 0.5% 
4.4% 
16.3%
10.4% 
2.0%
 17.9x
Pfizer 26.33 -1.4% 6.5% 7.4% 
-5.9% 
-22.8%
-14.4% 
0.8%
 12.3x
Danaher 175.15 -2.1% 0.7% 1.1% 
4.6% 
4.8%
4.7% 
-4.9%
 26.0x
Bristol-Myers Squibb 58.22 -3.9% 4.3% 7.0% 
2.8% 
85.8%
44.3% 
-0.9%
 19.4x
Equipment
Company / category Price and
change		 Year div-d yield FCF Yield LTM Last growth
Revenue/EBITDA		 AVG growth
last/hist		 EV/LTM EBITDA Express
potential		 Next IFRS report Value Creation
Price +/- Revenue EBITDA Last Hist. (exp) (p75)
Tesla 390.82 +2.4% 0.0% 0.6% 
11.6% 
-20.1%
-4.3% 
-0.4%
 114.1x
Raytheon Technologies 173.99 -1.2% 1.5% 2.0% 
12.1% 
15.5%
13.8% 
14.4%
 21.1x
Market Attractiveness Index

Market Attractiveness Index

calculated as average express-upside for TOP-5 US companies with highest potential

High values of index (>30%), indicate favorable moments for additional cash contributions to the stock market / stock purchases

Current value of the Index is 115.4%

chart technology by TradingView

Portfolios

Invest in a rotating portfolio of top US-based, non-financial companies. Strategy results are shown below. This page contains financial information on the 40 companies we screen for our portfolio. For a detailed overview of our US Leaders strategy and rationale behind it, follow the link

US Leaders
since 2019-08-25

-0.4%

0.3%
day

+0.2%

0.9%
week

+307.8%

154.0%
Since inception

0.0%

SP500
Since inception
KNOW MORE →

Target portfolio structure
Company Price Day change Week change target share Value Creation Web 3m traffic
58.22  -3.9%  -0.8% 28.0% 51.9%
112.16  +2.7%  +0.2% 22.3% 33.8%
157.41  -0.7%  +1.3% 11.2% 25.6%
91.85  +0.4%  +3.2% 10.8% 16.3%
414.44  +1.6%  -2.4% 10.7% 16.1%
268.26  +1.2%  +1.6% 8.8% 13.3%
89.46  -1.5%  -1.8% 8.2% 12.5%
Actual Performance
Period Strategy SP&500
 
2019 +9.9% +13.5%
2020 +14.2% +16.2%
2021 +30.6% +27.4%
2022 -17.1% -19.7%
2023 +58.3% +24.2%
2024 +37.6% +23.5%
2025 +29.6% +16.4%
2026 +6.2% +5.4%
 
Annualized +23.4% +14.9%
 
Day -0.4% +0.3%
Week +0.2% +0.9%
Year to date +6.2% 0.0%
Since inception (2019-08-25) +307.8% +154.0%
Maximum drawdown
28.5%
Date of drawdown
2022-09-30
Sharpe ratio
1.1
Volatility (year)
13%
Portfolio (USD) and S&P500 dynamics (%)
chart technology by TradingView

Reviews

2026-04-29
#reports #SBUX

Starbucks (Coffee selling company) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=SBUX&q=2026 q1&id=939021)
(2026-04-28, After Market Close):

- Revenue +8.8% YoY (vs +5.5% in previous quarter and historical rate +4.3%)
- EBITDA +17.6% YoY (vs -13.5% in previous quarter and historical rate -7.5%)
- EBITDA margin 13.1% increased compared to 12.1% same period last year
- Net Debt increased by $0.8 bln since the start of the year (0.7% of market cap)
- FCF (LTM) +$1.3 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 30x compared to historical level (75th percentile) of 21x

At the opening of the session the share price went up +8.2%
2026-04-26
(review)
Weekly results
for USD strategies

US Leaders: -1.7%

Global Commodities: +1.7%

Trending Ideas: +2.4%

Rising Stars: +4.1%

vs S&P500: +2.8%
2026-04-19
(review)
Weekly results
for USD strategies

US Leaders: +0.5%

Global Commodities: -0.3%

Trending Ideas: +2.0%

Rising Stars: +4.2%

vs S&P500: +2.2%
2026-04-12
(review)
Weekly results
for USD strategies

US Leaders: +1.1%

Global Commodities: +1.7%

Trending Ideas: 0.0%

Rising Stars: -2.2%

vs S&P500: +3.6%
2026-04-05
(review)
Weekly results
for USD strategies

US Leaders: +1.9%

Global Commodities: +8.4%

Trending Ideas: +0.7%

Rising Stars: 0.0%

vs S&P500: +3.4%
2026-03-29
(review)
Weekly results
for USD strategies

US Leaders: +1.0%

Global Commodities: +4.9%

Trending Ideas: +1.2%

Rising Stars: +2.0%

vs S&P500: -2.1%
2026-03-28
#reports #AVGO

Broadcom (Digital and analog semiconductors developer ) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=196175)
(2025-12-11, After Market Close):

- Revenue +29.5% YoY (vs +28.2% in previous quarter and historical rate +26.4%)
- EBITDA +36.1% YoY (vs +60.3% in previous quarter and historical rate +26.0%)
- EBITDA margin 45.1% increased compared to 42.9% same period last year
- Net Debt increased by $2.9 bln since the start of the year (0.2% of market cap)
- FCF (LTM) +$27.1 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 51.1x compared to historical level (75th percentile) of 62x
expected multiple is 42.8x

At the opening of the session the share price went down -6.6%

Growth potential decreased by 7.0% to -37.9%
2026-03-22
(review)
Weekly results
for USD strategies

US Leaders: -2.5%

Global Commodities: -9.0%

Trending Ideas: -1.7%

Rising Stars: -8.5%

vs S&P500: -1.9%
2026-03-15
(review)
Weekly results
for USD strategies

US Leaders: -1.1%

Global Commodities: -1.4%

Trending Ideas: -0.1%

Rising Stars: +2.6%

vs S&P500: -1.6%
2026-03-08
(review)
Weekly results
for USD strategies

US Leaders: -3.3%

Global Commodities: -8.5%

Trending Ideas: -1.4%

Rising Stars: -6.3%

vs S&P500: -2.0%
2026-03-01
(review)
Weekly results
for USD strategies

US Leaders: +1.3%

Global Commodities: +2.8%

Trending Ideas: +0.6%

Rising Stars: +0.6%

vs S&P500: -0.4%
2026-02-28
#reports #ABT

Abbott (Medical products and equipment manufacturer ) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=8&id=131825)
(2026-01-22, Before Market Open):

- Revenue +4.4% YoY (vs +6.9% in previous quarter and historical rate +0.9%)
- EBITDA +16.3% YoY (vs +10.9% in previous quarter and historical rate +3.0%)
- EBITDA margin 22.9% increased compared to 20.5% same period last year
- Net Debt increased by $8 bln since the start of the year (3.9% of market cap)
- FCF (LTM) +$8.8 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 22.9x compared to historical level (75th percentile) of 27.4x
expected multiple is 22.1x

The company showed EPS +$3.74 per share. At the opening of the session the share price went down -13.9%

Growth potential changed insignificantly and equals +24.4%
2026-02-28
#reports #ABBV

AbbVie ( Medicines manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195436)
(2026-02-04, Before Market Open):

- Revenue +10% YoY (vs +9.1% in previous quarter and historical rate +1.9%)
- EBITDA +474600% YoY (vs -47.9% in previous quarter and historical rate -4.9%)
- EBITDA margin 28.6% increased compared to -8.6% same period last year
- Net Debt decreased by $0.8 bln since the start of the year (0.2% of market cap)
- FCF (LTM) -$1.5 bln (negative), 0.4% of market cap
- EV/EBITDA multiple is 29.8x compared to historical level (75th percentile) of 37.6x
expected multiple is 44.3x

The company showed EPS +$2.38 per share. At the opening of the session the share price went down -7.0%

According to our model the company`s growth potential is negative
2026-02-26
#reports #NVDA

Nvidia (Developer of graphics processors) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195101)
(2026-02-25, After Market Close):

- Revenue +73.2% YoY (vs +62.5% in previous quarter and historical rate +103.6%)
- EBITDA +83.5% YoY (vs +64.5% in previous quarter and historical rate +116.1%)
- EBITDA margin 66.2% increased compared to 62.5% same period last year
- Net Debt increased by $1.5 bln since the start of the year (0.0% of market cap)
- FCF (LTM) +$31.3 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 35.8x compared to historical level (75th percentile) of 69.9x
expected multiple is 34.5x
2026-02-26
#reports #LOW

Lowes Cos (Building materials seller) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +10.9% YoY (vs +3.2% in previous quarter and historical rate -3.5%)
- EBITDA -4.7% YoY (vs +1.6% in previous quarter and historical rate -7.2%)
- EBITDA margin 11.4% decreased compared to 13.3% same period last year
- Net Debt decreased by $0.3 bln since the start of the year (0.2% of market cap)
- FCF (LTM) +$2.8 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 14.7x
2026-02-25
#reports #HD

Home Depot (Building materials and home improvement products retailer) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue -3.8% YoY (vs +2.8% in previous quarter and historical rate +1.7%)
- EBITDA -11.6% YoY (vs 0.0% in previous quarter and historical rate -3.5%)
- EBITDA margin 12.3% decreased compared to 13.4% same period last year
- Net Debt increased by $6.7 bln since the start of the year (1.7% of market cap)
- FCF (LTM) +$10.2 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 18.2x
expected multiple is 18.1x
2026-02-22
(review)
Weekly results
for USD strategies

US Leaders: +0.6%

Global Commodities: -1.3%

Trending Ideas: +1.0%

Rising Stars: -1.5%

vs S&P500: +1.1%
2026-02-20
#reports #WMT

Walmart (Chain of discount stores and supercenters) reported for 2025 q4
(2026-02-19, Before Market Open):

- Revenue +5.6% YoY (vs +5.8% in previous quarter and historical rate +5.3%)
- EBITDA +10.8% YoY (vs +3.4% in previous quarter and historical rate +13.7%)
- EBITDA margin 6.5% increased compared to 6.2% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (0.1% of market cap)
- FCF (LTM) -$6.5 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 24.4x compared to historical level (75th percentile) of 19.9x
expected multiple is 24.9x
2026-02-15
(review)
Weekly results
for USD strategies

US Leaders: -1.9%

Global Commodities: +3.4%

Trending Ideas: +1.6%

Rising Stars: +3.8%

vs S&P500: -1.4%
2026-02-11
#reports #KO

Coca-Cola (Soft drinks poducer) reported for [2025 q4](https://eninvs.com/press_release.php?ticker=KO&q=2025 q4&id=915065)
(2026-02-10, Before Market Open):

- Revenue +2.4% YoY (vs +5.1% in previous quarter and historical rate +3.7%)
- EBITDA -30.4% YoY (vs +53.0% in previous quarter and historical rate +10.2%)
- EBITDA margin 17.6% decreased compared to 25.9% same period last year
- Net Debt decreased by $1.9 bln since the start of the year (0.6% of market cap)
- FCF (LTM) -$2.2 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 24.6x compared to historical level (75th percentile) of 27.9x
expected multiple is 20.5x
2026-02-11
#reports #GILD

Gilead Sciences (Medicines manufacturer) reported for 2025 q4
(2026-02-10, After Market Close):

- Revenue +4.7% YoY (vs +3.0% in previous quarter and historical rate +1.1%)
- EBITDA -15.6% YoY (vs +96800.0% in previous quarter and historical rate +5.5%)
- EBITDA margin 31.8% decreased compared to 39.5% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (0.7% of market cap)
- FCF (LTM) +$0.6 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 62.5x